Plante Moran Financial Advisors’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-15
| Closed | -$4K | – | 1621 |
|
|
2026
Q1 | $4K | Buy |
+15
| New | +$4.06K | ﹤0.01% | 586 |
|
|
2025
Q1 | – | Sell |
-24
| Closed | -$5.5K | – | 896 |
|
|
2024
Q4 | $5.5K | Buy |
+24
| New | +$5.51K | ﹤0.01% | 670 |
|
|
2024
Q1 | – | Sell |
-125
| Closed | -$28.4K | – | 892 |
|
|
2023
Q4 | $28.4K | Hold |
125
| – | – | ﹤0.01% | 396 |
|
|
2023
Q3 | $25.1K | Sell |
125
-21
| -14% | -$4.43K | ﹤0.01% | 390 |
|
|
2023
Q2 | $30.2K | Hold |
146
| – | – | ﹤0.01% | 375 |
|
|
2023
Q1 | $28.7K | Hold |
146
| – | – | ﹤0.01% | 381 |
|
|
2022
Q4 | $29.4K | Hold |
146
| – | – | ﹤0.01% | 389 |
|
|
2022
Q3 | $26K | Hold |
146
| – | – | ﹤0.01% | 407 |
|
|
2022
Q2 | $29K | Hold |
146
| – | – | ﹤0.01% | 395 |
|
|
2022
Q1 | $33K | Sell |
146
-19
| -12% | -$4.47K | 0.01% | 395 |
|
|
2021
Q4 | $45K | Buy |
165
+19
| +13% | +$4.7K | 0.01% | 386 |
|
|
2021
Q3 | $35K | Hold |
146
| – | – | 0.01% | 449 |
|
|
2021
Q2 | $34K | Hold |
146
| – | – | 0.01% | 448 |
|
|
2021
Q1 | $32K | Hold |
146
| – | – | 0.01% | 449 |
|
|
2020
Q4 | $25K | Hold |
146
| – | – | 0.01% | 480 |
|
|
2020
Q3 | $24K | Hold |
146
| – | – | 0.01% | 458 |
|
|
2020
Q2 | $21K | Hold |
146
| – | – | 0.01% | 420 |
|
|
2020
Q1 | $16K | Hold |
146
| – | – | 0.01% | 424 |
|
|
2019
Q4 | $21K | Hold |
146
| – | – | 0.01% | 455 |
|
|
2019
Q3 | $21K | Hold |
146
| – | – | 0.01% | 482 |
|
|
2019
Q2 | $22K | Hold |
146
| – | – | 0.01% | 466 |
|
|
2019
Q1 | $19K | Sell |
146
-157
| -52% | -$19.3K | 0.01% | 479 |
|
|
2018
Q4 | $33K | Sell |
303
-157
| -34% | -$21K | 0.01% | 365 |
|
|
2018
Q3 | $69K | Hold |
460
| – | – | 0.02% | 252 |
|
|
2018
Q2 | $71K | Sell |
460
-21
| -4% | -$3.17K | 0.04% | 268 |
|
|
2018
Q1 | $67K | Buy |
481
+3
| +0.6% | +$441 | 0.04% | 297 |
|
|
2017
Q4 | $66K | Buy |
478
+314
| +191% | +$41.5K | 0.04% | 293 |
|
|
2017
Q3 | $21K | Sell |
164
-1
| -0.6% | -$133 | 0.01% | 456 |
|
|
2017
Q2 | $22K | Buy |
165
+19
| +13% | +$2.33K | 0.01% | 456 |
|
|
2017
Q1 | $18K | Sell |
146
-24
| -14% | -$2.84K | 0.01% | 491 |
|
|
2016
Q4 | $19K | Sell |
170
-124
| -42% | -$13.8K | 0.01% | 492 |
|
|
2016
Q3 | $35K | Buy |
294
+148
| +101% | +$17.4K | 0.02% | 386 |
|
|
2016
Q2 | $16K | Hold |
146
| – | – | 0.01% | 462 |
|
|
2016
Q1 | $15K | Hold |
146
| – | – | 0.01% | 418 |
|
|
2015
Q4 | $15K | Hold |
146
| – | – | 0.01% | 500 |
|
|
2015
Q3 | $14K | Hold |
146
| – | – | 0.01% | 434 |
|
|
2015
Q2 | $15K | Hold |
146
| – | – | 0.01% | 461 |
|
|
2015
Q1 | $16K | Hold |
146
| – | – | 0.01% | 438 |
|
|
2014
Q4 | $13K | Hold |
146
| – | – | 0.01% | 484 |
|
|
2014
Q3 | $13K | Sell |
146
-145
| -50% | -$13.1K | 0.01% | 487 |
|
|
2014
Q2 | $26K | Hold |
291
| – | – | 0.02% | 343 |
|
|
2014
Q1 | $25K | Hold |
291
| – | – | 0.03% | 228 |
|
|
2013
Q4 | $23K | Hold |
291
| – | – | 0.01% | 333 |
|
|
2013
Q3 | $25K | Buy |
291
+145
| +99% | +$12.2K | 0.02% | 265 |
|
|
2013
Q2 | $13K | Buy |
+146
| New | +$12.1K | 0.01% | 303 |
|
Other funds holding LH
Plante Moran Financial Advisors's LH Position: Q2 2026 in Review
Plante Moran Financial Advisors sold out of Labcorp (LH) in Q2 2026, closing a stake of 15 shares — an estimated $4K sold.
Plante Moran Financial Advisors first reported a position in LH in Q2 2013 and held it in 45 quarters. The position peaked at $71K in Q2 2018. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Plante Moran Financial Advisors reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
- Plante Moran Financial Advisors sold 15 Labcorp shares in Q2 2026, an estimated $4K.
- Plante Moran Financial Advisors first reported a position in Labcorp in Q2 2013 and held it in 45 quarters.
- Plante Moran Financial Advisors's Labcorp position peaked at $71K in Q2 2018.
- 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.